Panodil
Sponsors
Akl Research & Development Limited, Peptinov, KeyBioscience S.A., Amzell B.V.
Conditions
Knee OsteoarthritisKnee osteoarthritisObesity
Phase 2
A placebo-controlled, double-blinded, randomized, dose-finding trial using a combination of apocynin and paeonol (APPA) for the treatment of knee osteoarthritis
CompletedCTIS2023-508791-11-00
Start: 2024-07-08End: 2025-06-23Target: 170Updated: 2025-01-24
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy in Patients with Inflammatory Knee Osteoarthritis (KOA).
Not yet recruitingCTIS2024-514388-24-00
Target: 204Updated: 2025-04-07
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-336 as an Adjunct to Diet and Exercise in Obese Individuals with Osteoarthritis of the Knee
Active, not recruitingCTIS2024-517264-27-00
Start: 2024-12-13Target: 495Updated: 2025-10-09